Patent Appeal Board Reverses Rejection in In Re Xu
News @ Myers Bigel In March 2009, the Board of Patent Appeals and Interferences held in In re Xu that a patent examiner who rejected an application for a prostate cancer risk screening method based on post-filing data indicating the method did…